Oaktree Acquisition Corp. III Life Sciences (OACC) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は Los Angeles, CA, アメリカ. 現CEOは Mathew Pendo.
OACC を有する IPO日 2024-12-16, 3 名の正社員, に上場 NASDAQ Global Market, 時価総額 $262.54M.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
